Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

Reconstructing Indian population history

(2009) David Reich et al.   NATURE

Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

VKORC1haplotypes in five East-Asian populations and Indians

(2009) Ming Ta Michael Lee et al.   PHARMACOGENOMICS

Genetic determinants of warfarin dosing in the Han-Chinese population

(2009) MT Michael Lee et al.   PHARMACOGENOMICS

A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose

(2009) Fumihiko Takeuchi et al.   PLoS Genetics

Prevalence in the United States of Selected Candidate Gene Variants: Third National Health and Nutrition Examination Survey, 1991-1994

(2008) M.-h. Chang et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Warfarin Pharmacogenetics: CYP2C9 and VKORC1 Genotypes Predict Different Sensitivity and Resistance Frequencies in the Ashkenazi and Sephardi Jewish Populations

(2008) Stuart A. Scott et al.   AMERICAN JOURNAL OF HUMAN GENETICS

African Genetic Diversity: Implications for Human Demographic History, Modern Human Origins, and Complex Disease Mapping

(2008) Michael C. Campbell et al.   Annual Review of Genomics and Human Genetics

CYP4F2 genetic variant alters required warfarin dose

(2008) M. D. Caldwell et al.   BLOOD

VKORC1 Asp36Tyr warfarin resistance marker is common in Ethiopian individuals

(2008) E. Aklillu et al.   BLOOD

Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement

(2008) D. Wang et al.   BLOOD

The largest prospective warfarin-treated cohort supports genetic forecasting

(2008) M. Wadelius et al.   BLOOD

A genome-wide scan for common genetic variants with a large influence on warfarin maintenance dose

(2008) G. M. Cooper et al.   BLOOD

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

(2008) BF Gage et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Dosing Algorithms to Predict Warfarin Maintenance Dose in Caucasians and African Americans

(2008) H Schelleman et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

VKORC1polymorphisms, haplotypes and haplotype groups on warfarin dose among African–Americans and European–Americans

(2008) Nita A Limdi et al.   PHARMACOGENOMICS

Influence ofCYP2C9andVKORC1on warfarin dose, anticoagulation attainment and maintenance among European–Americans and African–Americans

(2008) Nita A Limdi et al.   PHARMACOGENOMICS